author-photo

Suparna B. Wedam

Food and Drug Administration

3

Papers

2

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Overall survival in patients with breast cancer treated with a CDK 4/6 inhibitor plus fulvestrant: A U.S. Food and Drug Administration pooled analysis.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)